Many microalgae acquire vitamin B 12 from marine prokaryotes. A new study demonstrates that vitamin B 12 is synthesized by planktonic cyanobacteria as pseudocobalamin, a form not bioactive in microalgae. However, some microalgae can remodel pseudocobalamin to the active cobalamin form, adding complexity to our assessment of active vitamin B 12 in the environment.
Most organisms experience a myriad of interactions with other organisms, which, along with abiotic environmental conditions, creates a dynamic biotic population within an ecological community. In some very rare instances, these interactions may even lead to endosymbiosis and the establishment of an organelle (for example, a primary endosymbiotic event led to the evolution of mitochondria and chloroplasts) [1, 2] . There is more and more interest in the ways in which organisms interact and exchange metabolites and sense signaling molecules in their natural environment. Recent efforts have explored the roles of the gut microbiome in human health [3] , metabolite exchange between the Symbiodinium endosymbiont and its cnidarian host in coral reef ecosystems [4] , and the fixation of nitrogen by Rhizobia that reside in root nodules of legumes, coupled to exchange of reduced nitrogen compounds for fixed carbon generated by photosynthesis in the plant [5] . We are also beginning to learn more about specific metabolite exchange processes that link single-celled organisms [6] . While many interactions among organisms may be critical for exchanging metabolites, they may not involve an intimate, sustained association between the organisms and therefore will not be as apparent as those interactions that occur between legume roots and bacteria, or the coral and its associated alga.
While the synthesis of specific 'vital' molecules may be limited to a particular group of organisms, they are needed by other organisms to maintain proper growth and development. Included among the molecules critical for growth and development of many eukaryotes, but restricted in its synthesis to various prokaryotes, is vitamin B 12 [7] . There are several studies that indicate that heterotrophic bacteria can satisfy the demands of microalgae for vitamin B 12 [8, 9] , and that certain cyanobacteria can release high levels of vitamin B 12 to the environment [10] . The new article by Helliwell et al. [11] in this issue of Current Biology addresses the issue of the production of the vitamin B 12 variants (vitamers), cobalamin and pseudocobalamin, by cyanobacteria, and the ability of planktonic eukaryotic microalgae to use these different vitamers. A surprising finding of this study is that various microalgae can turn the 'biologically inactive' pseudocobalamin B 12 vitamer into its 'biologically active' form, in a process that has been termed vitamin 'remodeling'.
Many eukaryotes, including microalgae, require exogenous B vitamins such as vitamin B 1 (thiamine), B 7 (biotin) and B 12 for growth [12] . Vitamin B 12 is a corrinoid cofactor synthesized by many bacteria [12] , and nearly all oxygenic photosynthetic cyanobacteria, but it is not made by eukaryotic organisms. Figure 1A depicts organisms across the tree of life that synthesize vitamin B 12 (eubacteria and archaebacteria) and those that require exogenous vitamin B 12 for growth (many eukaryotes). The only classes of eukaryotic organisms that do not appear to require vitamin B 12 at all are the plants and fungi -enzymes dependent on vitamin B 12 are not used in these organisms. Various forms of vitamin B 12 are derived from the tetrapyrrole biosynthetic pathway, diverging from the pathway for heme and chlorophyll biosynthesis at the uroporphyrinogen III step (with 20 additional enzymatic modifications to generate a final vitamer). The B 12 vitamers contain a central cobalt ion that associates with both an upper and lower axial ligand. Variation in the upper axial ligand alters the specificity of the cofactor for biochemical reactions, while variation of the lower axial ligand can significantly alter the effectiveness of the cofactor. The vitamin B 12 that is 'bioactive' for humans and a number of other eukaryotes is cobalamin (and variants). While many heterotrophic bacteria synthesize cobalamin, Helliwell and colleagues showed that most cyanobacteria, including both marine and freshwater species, make a vitamin B 12 variant called pseudocobalamin (that the cyanobacteria themselves are able to use). Nearly all of these photosynthetic prokaryotes appear unable to synthesize cobalamin. The difference between cobalamin and pseudocobalamin is that in the former the lower axial ligand to the cobalt ion is 5,6-dimethylbenzimidizole (DMB) while in the latter it is adenine. This is shown in the structure of the two B 12 vitamers in Figure 1B . Indeed, based on a bioinformatics survey of 123 cyanobacterial genomes, Helliwell and colleagues [11] showed that most of the cyanobacteria do not have the genetic capabilities to synthesize the DMB moiety associated with the lower axial ligand of cobalamin; genes encoding the BluB enzyme and the bzaABCDE operon, bacterial genes involved in DMB synthesis, were absent from nearly all cyanobacterial genomes examined. Furthermore, extracts from Synechococcus strains (dominant planktonic cyanobacteria) only contained pseudocobalamin (not cobalamin), and these cyanobacteria were not able to make cobalamin even if the growth medium was supplemented with DMB.
Marine and freshwater microalgae, like many other eukaryotes, require exogenous vitamin B 12 as a cofactor for specific enzymatic reactions; these reactions are represented in Figure 1C . Also, like for humans, the bioactive form of vitamin B 12 for microalgae is cobalamin and not pseudocobalamin. Indeed, Helliwell and colleagues tested a number of microalgae for their ability to use cobalamin and pseudocobalamin and found that essentially all of the microalgae, including Ostreococcus tauri (Mamiellophyceae), Amphidinium carterae (Dinoflagellate), Pavlova lutheri (Prymnesiophyceae), Thalassiosira pseudonana (Coscinodiscophyceae), Aureococcus anophagefferens (Pelagophyceae) and Lobomonas rostrata (Volvocales) and the vitamin B 12 -dependent metE mutant of Chlamydmonas reinhardtii (Volvocales), were able to grow at very low levels of cobalamin (0.07 nM), while generally much higher levels of pseudocobalamin (e.g., 7 nm) allowed for some growth of some of these algae -this high level of pseudocobalamin is well beyond physiological levels (well beyond levels detected in the environment). Indeed, cobalamin levels in the environment can be picomolar, or even below the level of detection [13] .
While a requirement of microalgae for cobalamin was not surprising, it was surprising to find that some of the alga that were unable to grow on low levels of pseudocobalamin could grow if, in addition to pseudocobalamin, DMB was included in the medium. The algae that responded to DMB included P. lutheri and the vitamin B 12 -dependent mutant of C. reinhardtii; other algae like O. tauri, A. carterae, T. pseudonana and L. rostrata did not respond to DMB. These results suggest that specific microalgae are able to convert the pseudocobalamin into cobalamin or another vitamer that supports vitamin B 12 -dependent growth; this likely occurs by remodeling of the lower axial adenine ligand of the former using the exogenous DMB (although the authors were not able to prove this biochemically). This conclusion was further supported by the finding that, like cobalamin [14] , DMB plus pseudocobalamin represses expression from the promoter of C. reinhardtii METE (pseudocobalamin does not suppress expression), and also that genes encoding proteins implicated in the assembly of the lower axial ligand through the generation of the nucleotide loop and DMB attachment at the lower axial position are encoded in the C. reinhardtii genome.
The work by Helliwell and colleagues emphasizes the potential importance of the production of pseudocobalamin by cyanobacteria and its remodeling for bioactivity by eukaryotic microalgae (and potentially other eukaryotes). The findings suggest that specific molecules can be modified and assembled from building blocks in the environment to make bioactive compounds such as cobalamin; currently there is little known about this 'lego' synthetic mechanism, how broadly it is used (and for which molecules) and the origin of the different lego pieces. This realization makes it more complicated to assess the potential limitations for active biomolecules in the environment and raises numerous questions concerning modes of biomolecule synthesis and their modification, mobility and utilization. It also raises the possibility of coevolution of integrating segments of biosynthetic pathways among populations of organisms in an ecosystem. The pollen tube of flowering plants undertakes a long journey to transport two sperm cells for double fertilization. New work on pollen tube guidance has identified an arabinogalactan-derived ovular factor that primes tubes to respond to female gametophyte-secreted attraction signals.
Fertilization in flowering plants (angiosperms) is the most complex among all organisms, because it involves the generation and function of multicellular gametophytes [1] . After two mitotic cell divisions, male gametophytesconsisting of the haploid pollen tube cell and two enclosed sperm cells -are formed after meiosis from microspores. Female gametophytes -consisting of two female gametes, the haploid egg and di-haploid central cell, and accessory cells at both poles -are generated in the ovule from megaspores after three mitotic nuclei divisions ( Figure 1 ) [2] . After sperm cell release and cell fusions, the fertilized egg cell or zygote develops into a diploid embryo, and the fertilized central cell produces the triploid endosperm.
Together with the sporophytic maternal tissues of the ovule, they form the seed.
One of the major developments in the angiosperm lineage is that the ovules are enclosed within a carpel -a structure consisting of the stigma, where pollen tubes germinate, a style and the ovary, harboring one or many ovules. It has been a long-standing question as to how pollen tubes make their way from the stigma, through the transmitting tract of the style and ovary, and into the micropylar opening of the ovule(s). The past decade has shown that during their journey, tubes communicate extensively with the surrounding sporophytic maternal tissues, and important peptide-mediated signaling processes have been discovered that regulate germination and growth support, guidance, sperm cell release and activation [3] [4] [5] . However, these studies also revealed that fully in vitro-germinated and -grown pollen tubes of the eudicot model plants Torenia fournieri (wishbone flower) and Arabidopsis thaliana (thale cress) are not capable of growing into ovules and nor do they react to agarose beads releasing the peptide attractant(s) [5] . Therefore, a SIV (semi-in vivo or semiin vitro) assay was established for both species in which pollen tubes germinate on the stigma, enter the transmitting tract of the style and exit the tract to grow towards excised ovules exposed in the vicinity of the cut styles [6, 7] . In conclusion, these previous findings indicated that during their journey, pollen tubes acquire competence to respond to female attraction signals secreted from the ovule and embryo sac, respectively. Indeed the gene expression patterns of pollen tubes of both species change significantly after growing through the sporophytic tissues of the style [8, 9] ,
